Lv4
534 积分 2024-01-07 加入
Effect of Doxorubicin Plus Olaratumab vs Doxorubicin Plus Placebo on Survival in Patients With Advanced Soft Tissue Sarcomas
1个月前
已完结
Canakinumab Versus Placebo in Combination With First-Line Pembrolizumab Plus Chemotherapy for Advanced Non–Small-Cell Lung Cancer: Results From the CANOPY-1 Trial
1个月前
已完结
Motixafortide and Pembrolizumab Combined to Nanoliposomal Irinotecan, Fluorouracil, and Folinic Acid in Metastatic Pancreatic Cancer: The COMBAT/KEYNOTE-202 Trial
1个月前
已完结
Foundation models in oncology win benchmarks but miss the clinic
1个月前
已完结
Non-small-cell lung cancer
2个月前
已完结
Immunocytokines and cytokine neutralization for cancer immunotherapy
2个月前
已完结
Cancer-associated fibroblasts and M2-polarized macrophages synergize during prostate carcinoma progression
3个月前
已完结
Stromal Reprogramming through Dual PDGFRα/β Blockade Boosts the Efficacy of Anti–PD-1 Immunotherapy in Fibrotic Tumors
3个月前
已完结
Targeting CTGF in Cancer: An Emerging Therapeutic Opportunity
3个月前
已完结
Targeting the IL-6/JAK/STAT3 signalling axis in cancer
3个月前
已完结
皖公网安备34019202002308
